Stem cell shot into ovaries aims to tame perimenopause symptoms
NCT ID NCT07511660
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether injecting special stem-like cells called Muse cells directly into the ovaries can help women aged 28 to 70 who are in perimenopause. The cells may repair tissue, reduce inflammation, and improve hormone balance. Researchers will track safety, hormone levels, and quality of life for 24 months. The goal is to see if this approach can ease symptoms like hot flashes and mood changes without long-term medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELL THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stem Solutions
Monterrey, Nuevo León, 64000, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Smartwatch could spot nerve damage before it starts
- Can healing at home beat hospital care for bedsores?
- Talking therapy may cool hot flushes for NHS workers
- Gut bacteria may soothe menopause symptoms — a trial puts it to the test